MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517092061 A) filed by Beone Medicines I Gmbh, Basel, Switzerland, on Sept. 25, for 'muc1 and cd16a antibodies and methods of use.'
Inventor(s) include Li, Hui; Ren, Qiansheng; Qu, Liang; Jiang, Ming; Liu, Qi; Chen, Xin; Chen, Yun; Xue, Liu; Wang, Wenjie; Pan, Jie; Li, Zhuo; Tang, Xiaoyan; Huang, Chichi; and Shao, Ting.
The application for the patent was published on Oct. 10, under issue no. 41/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure provides for multi-specific antibodies and antigen-binding fragments thereof that bind to human MUC1 and CD16A, pharmaceutical compositions comprising said antibodies, and use of the antibodies or the compositions for treating a disease, such as cancer."
The patent application was internationally filed on Mar. 01, 2024, under International application No.PCT/CN2024/079593.
Disclaimer: Curated by HT Syndication.
